Skip to content

FeNO Observation Study in ICU Patients With ARS

An Observational Study of Fractional Exhaled Nitric Oxide Concentration in Patients With Advanced Respiratory Support

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06680895
Enrollment
1000
Registered
2024-11-08
Start date
2024-07-01
Completion date
2025-12-31
Last updated
2024-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Compare the Concentration of Exhaled Nitric Oxide in Patients With Different Severity of RF

Brief summary

1. Main Objective: To compare the concentration of exhaled nitric oxide in patients with different severity of respiratory failure in ICU. 2. Secondary Purpose: 1. To observe the change of nitric oxide concentration in exhaled breath of patients with mechanical ventilation over time; 2. The relationship and differences between pulmonary ventilation blood flow levels in patients with different exhaled NO concentrations; 3. Reactivity of patients with different exhaled NO concentrations to inhaled nitric oxide therapy and the relationship between them.

Interventions

OTHERFeNO Observation

FeNO was observed and measured among patients with advanced respiratory support

Sponsors

Shanghai Zhongshan Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years

Inclusion criteria

1. Adult patients (≥18 years of age) with mechanical ventilation or advanced respiratory support in the ICU, regardless of gender; 2. The expected mechanical ventilation time of tracheal intubation is more than 24 hours; 3. The initial ventilator Settings of clinical routine were adopted: oxygen fraction (FIO2) = 50%, respiratory rate = 15/min, positive end-expiratory pressure (PEEP) = 5 cmH2O, tidal volume = 6-8 ml/kg ideal body weight (IBW), inspiration-exhalation ratio =1:2; 4. Agree to participate in this experiment and sign the informed consent.

Exclusion criteria

* 1.Use of any NO-containing drugs (such as nitroglycerin), anti-inflammatory drugs, or drugs or means that affect the airway diameter within 6 hours before the first FeNO measurement; 2. Participating in other clinical research projects; 3. Patients deemed unsuitable by the investigators.

Design outcomes

Primary

MeasureTime frameDescription
FeNO concentration1.5 yearExhaled nitric oxide concentration of patients with different severity of respiratory failure in ICU

Countries

China

Contacts

Primary ContactHuan Wang, Master
wang.huan@zs-hospital.sh.cn13472735075

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026